BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27911072)

  • 41. Organizational context, systems change, and adopting treatment delivery systems in the criminal justice system.
    Taxman FS; Henderson CE; Belenko S
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1():S1-6. PubMed ID: 19423241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Federal policy on criminal offenders who have substance use disorders: how can we maximize public health and public safety?
    Humphreys K
    Subst Abus; 2012; 33(1):5-8. PubMed ID: 22263708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breaking the addictive cycle of the system: improving US criminal justice practices to address substance use disorders.
    Kopak AM
    Int J Prison Health; 2015; 11(1):4-16. PubMed ID: 25751703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treating substance use disorders in the criminal justice system.
    Belenko S; Hiller M; Hamilton L
    Curr Psychiatry Rep; 2013 Nov; 15(11):414. PubMed ID: 24132733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Organizational characteristics of drug abuse treatment programs for offenders.
    Grella CE; Greenwell L; Prendergast M; Farabee D; Hall E; Cartier J; Burdon W
    J Subst Abuse Treat; 2007 Apr; 32(3):291-300. PubMed ID: 17383553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lifting the cover on drug courts: evaluation findings and policy concerns.
    Sanford JS; Arrigo BA
    Int J Offender Ther Comp Criminol; 2005 Jun; 49(3):239-59. PubMed ID: 15851506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incarceration and psychotropic drug use by youth.
    Cuellar AE; Kelleher KJ; Kataoka S; Adelsheim S; Cocozza JJ
    Arch Pediatr Adolesc Med; 2008 Mar; 162(3):219-24. PubMed ID: 18316658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Economic impact of psychiatric relapse and recidivism among adults with schizophrenia recently released from incarceration: a Markov model analysis.
    Lin I; Muser E; Munsell M; Benson C; Menzin J
    J Med Econ; 2015 Mar; 18(3):219-29. PubMed ID: 25266814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prison-based substance abuse treatment, residential aftercare and recidivism.
    Hiller ML; Knight K; Simpson DD
    Addiction; 1999 Jun; 94(6):833-42. PubMed ID: 10665073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated services plus drug treatment as a system alternative to crime control and parole.
    Danzer G
    Soc Work Public Health; 2012; 27(7):687-98. PubMed ID: 23145552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overcoming Impediments to OTP Expansion in the United States and Abroad.
    Parrino MW
    Subst Use Misuse; 2018 Jan; 53(2):354-355. PubMed ID: 29244540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The 21st Century Cures Act Implications for the Reduction of Racial Health Disparities in the US Criminal Justice System: a Public Health Approach.
    Cole DM; Thomas DM; Field K; Wool A; Lipiner T; Massenberg N; Guthrie BJ
    J Racial Ethn Health Disparities; 2018 Aug; 5(4):885-893. PubMed ID: 29124683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Economic evaluation of a prerelease substance abuse treatment program for repeat criminal offenders.
    French MT; Fang H; Fretz R
    J Subst Abuse Treat; 2010 Jan; 38(1):31-41. PubMed ID: 19631489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opioid addiction and incarceration: an overview.
    Schwartz RP; McKenzie M; Rich JD
    Med Health R I; 2007 May; 90(5):157-8. PubMed ID: 17557660
    [No Abstract]   [Full Text] [Related]  

  • 56. Organizational-level correlates of the provision of detoxification services and medication-based treatments for substance abuse in correctional institutions.
    Oser CB; Knudsen HK; Staton-Tindall M; Taxman F; Leukefeld C
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1(Suppl 1):S73-81. PubMed ID: 19108957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug treatments in criminal justice settings.
    Nordstrom BR; Williams AR
    Psychiatr Clin North Am; 2012 Jun; 35(2):375-91. PubMed ID: 22640761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Criminal justice responses to drug related crime in Scotland.
    Malloch M; McIvor G
    Int J Drug Policy; 2013 Jan; 24(1):69-77. PubMed ID: 22809480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding the importance of organizational and system variables on addiction treatment services within criminal justice settings.
    McCarty D; Chandler RK
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1():S91-3. PubMed ID: 19356862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How do probation officers assess and manage recidivism and violence risk for probationers with mental disorder? An experimental investigation.
    Louden JE; Skeem JL
    Law Hum Behav; 2013 Feb; 37(1):22-34. PubMed ID: 22468760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.